Karimah Es Sabar

Karimah Es Sabar is a member of the board of ITIF's Centre for Canadian Innovation and Competitiveness.

A highly-recognized Canadian life sciences leader with broad international experience, Es Sabar has had a successful career spanning the global biopharmaceutical industry, start-ups, not-for-profit organizations and venture investment. Decades of experience nurturing and building high impact teams and organizations, she has provided leadership in international marketing, business development, strategic alliances, public private partnerships, developing and executing innovation and translation strategies, innovation ecosystems, entrepreneurship in startups, and in health technology venture capital investments. Over the course of her career, she has raised over $1.5B for various private and public global biosciences enterprises.

In 2016, she accepted the position of CEO and partner at Quark Venture LP to lead and build their health sciences enterprise. Through a joint venture with GF Securities the Global Health Sciences (GHS) Fund was established with operations headquartered in Vancouver, Canada and offices in Boston, Berkley, Hong Kong and Chengdu. The diversified GHS Fund invests globally in health bioscience companies with disruptive platforms and technologies.